Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Maintenance Gemcitabine in Advanced NSCLC
NCT01336192Phase 4Unknown
- Sponsor
- Tongji University
- Start
- Apr 2011
- Primary completion
- Apr 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of gemcitabine in non-small cell lung cancer (NSCLC), sponsored by Tongji University. Status: unknown.
02
Drugs
gemcitabine
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT01336192.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01336192.